KR102500496B1 - 프로바이오틱 조성물 및 이의 사용 - Google Patents

프로바이오틱 조성물 및 이의 사용 Download PDF

Info

Publication number
KR102500496B1
KR102500496B1 KR1020197022803A KR20197022803A KR102500496B1 KR 102500496 B1 KR102500496 B1 KR 102500496B1 KR 1020197022803 A KR1020197022803 A KR 1020197022803A KR 20197022803 A KR20197022803 A KR 20197022803A KR 102500496 B1 KR102500496 B1 KR 102500496B1
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
plantarum
composition according
cells
dsm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197022803A
Other languages
English (en)
Korean (ko)
Other versions
KR20190104568A (ko
Inventor
다니엘 아가드
이리니 라조우 아렌
라르스 니클라스 라르손
Original Assignee
프로비 에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1700542.2A external-priority patent/GB201700542D0/en
Priority claimed from GBGB1709731.2A external-priority patent/GB201709731D0/en
Application filed by 프로비 에이비 filed Critical 프로비 에이비
Publication of KR20190104568A publication Critical patent/KR20190104568A/ko
Application granted granted Critical
Publication of KR102500496B1 publication Critical patent/KR102500496B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
KR1020197022803A 2017-01-12 2018-01-12 프로바이오틱 조성물 및 이의 사용 Active KR102500496B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1700542.2A GB201700542D0 (en) 2017-01-12 2017-01-12 Probiotic compositions and uses thereof
GB1700542.2 2017-01-12
GBGB1709731.2A GB201709731D0 (en) 2017-06-19 2017-06-19 Probiotic compositions and uses thereof
GB1709731.2 2017-06-19
PCT/EP2018/050789 WO2018130667A1 (en) 2017-01-12 2018-01-12 Probiotic compositions and uses thereof

Publications (2)

Publication Number Publication Date
KR20190104568A KR20190104568A (ko) 2019-09-10
KR102500496B1 true KR102500496B1 (ko) 2023-02-16

Family

ID=61386800

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197022803A Active KR102500496B1 (ko) 2017-01-12 2018-01-12 프로바이오틱 조성물 및 이의 사용

Country Status (14)

Country Link
US (1) US11166993B2 (https=)
EP (1) EP3568144B1 (https=)
JP (1) JP7089523B2 (https=)
KR (1) KR102500496B1 (https=)
CN (1) CN110177561B (https=)
AU (1) AU2018207946B2 (https=)
BR (1) BR112019014418A2 (https=)
CA (1) CA3049624A1 (https=)
CL (1) CL2019001938A1 (https=)
MX (1) MX2019008292A (https=)
MY (1) MY195253A (https=)
PH (1) PH12019501629A1 (https=)
RU (1) RU2763311C2 (https=)
WO (1) WO2018130667A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112584848A (zh) * 2018-06-18 2021-03-30 普罗比公司 益生菌组合物及其用途
IT201900014550A1 (it) * 2019-08-09 2021-02-09 Abiogen Pharma Spa Uso di colecalciferolo come agente attivo nel trattamento della celiachia
CN116869141A (zh) * 2022-05-05 2023-10-13 内蒙古一康健康发展有限责任公司 一种具有保健功能的益生菌复合物及其制备方法
KR102845919B1 (ko) * 2023-02-28 2025-08-14 주식회사 피엘비앤비 장내 유해세균의 성장 억제 성능이 우수한 한국인 모유 유래 락티카제이바실러스 파라카제이 pl1536 및 이를 유효성분으로 포함하는 기능성식품 조성물
CN119279210A (zh) * 2024-12-16 2025-01-10 山东健源生物科技有限公司 一种复合益生菌发酵含药食同源物质的多谷物后生元制剂及其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013192163A1 (en) 2012-06-18 2013-12-27 H.J. Heinz Company Gluten-related disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004076615A2 (en) * 2003-02-27 2004-09-10 Bioneer A/S Immunomodulating probiotic compounds
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
ZA200802934B (en) * 2005-10-06 2009-09-30 Probi Ab Use of lactobacillus for treatment of virus infections
AU2006297896B2 (en) 2005-10-06 2011-12-08 Probi Ab Use of lactobacillus for treatment of autoimmune diseases
DK1996696T3 (en) 2006-03-17 2017-03-20 Probi Ab Thermostable lactobacillus strains
WO2007108763A1 (en) 2006-03-17 2007-09-27 Probac Ab Use of lactobacillus strains for promoting immunotolerance in autoimmune disease
CN102438643B (zh) 2008-11-30 2015-07-01 免疫桑特公司 用于治疗乳糜泻的组合物和方法
EP2581461B1 (en) * 2011-10-14 2014-09-24 GenMont Biotech Incorporation Composition and use of lactobacillus paracasei strain GMNL-133 in treating atopic dermatitis or other allergic diseases
US10245290B2 (en) * 2013-04-03 2019-04-02 Probi Ab Probiotic strains for use in treatment or prevention of osteoporosis
ES2764210T3 (es) * 2014-11-25 2020-06-02 Dsm Ip Assets Bv Lactobacillus para usar como probiótico

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013192163A1 (en) 2012-06-18 2013-12-27 H.J. Heinz Company Gluten-related disorders

Also Published As

Publication number Publication date
RU2763311C2 (ru) 2021-12-28
US20190358275A1 (en) 2019-11-28
WO2018130667A1 (en) 2018-07-19
EP3568144C0 (en) 2024-05-08
CL2019001938A1 (es) 2019-09-27
CA3049624A1 (en) 2018-07-19
AU2018207946A1 (en) 2019-07-25
AU2018207946B2 (en) 2024-07-18
RU2019121145A3 (https=) 2021-04-26
EP3568144A1 (en) 2019-11-20
RU2019121145A (ru) 2021-02-12
JP7089523B2 (ja) 2022-06-22
US11166993B2 (en) 2021-11-09
JP2020513780A (ja) 2020-05-21
CN110177561B (zh) 2023-09-12
EP3568144B1 (en) 2024-05-08
KR20190104568A (ko) 2019-09-10
BR112019014418A2 (pt) 2020-04-14
MX2019008292A (es) 2019-09-16
MY195253A (en) 2023-01-11
PH12019501629A1 (en) 2020-06-01
CN110177561A (zh) 2019-08-27

Similar Documents

Publication Publication Date Title
KR102500496B1 (ko) 프로바이오틱 조성물 및 이의 사용
US10588925B2 (en) Composition for inducing proliferation or accumulation of regulatory T cells
JP6182628B2 (ja) 免疫疾患の処置において使用するための、プロバイオティック細菌を含む組成物
Miyazawa et al. Heat-killed Lactobacillus gasseri can enhance immunity in the elderly in a double-blind, placebo-controlled clinical study
Braat et al. Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function
Sashihara et al. An analysis of the effectiveness of heat-killed lactic acid bacteria in alleviating allergic diseases
JP2023015099A (ja) 制御性ｔ細胞の増殖または集積を誘導するヒト由来細菌
RU2417092C2 (ru) Применение lactobacillus для лечения аутоиммунных заболеваний
JP2008099632A (ja) 免疫賦活作用・抗アレルギー作用を有する乳酸菌
KR101234435B1 (ko) 면역 부활용 조성물
JPWO2006093313A1 (ja) Ｔ細胞アポトーシス誘導剤
JP2009173548A (ja) 腸内細菌叢改善組成物、アレルギー抑制組成物、およびアレルギー抑制剤
HK40075389B (en) Composition for inducing proliferation or accumulation of regulatory t cells
EP4697983A1 (en) Human milk oligosaccharides
HK40075389A (en) Composition for inducing proliferation or accumulation of regulatory t cells

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 4